Site updated at Wednesday, 22 June 2016

Living with Dementia


Cancer drug prevents build-up of toxic brain protein

Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson’s disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects.

They say their study, published online May 10 in… Cancer drug prevents build-up of toxic brain protein   

Living With Dementia

alpha-synuclein7 - vitamin b12 deficiency1 - beta-blocker drugs1 - parkinsons diagnosis1 - deep brain stimulation2 - early-onset alzheimer's1 - schizophrenia1 - mild alzheimer's stage1 - structural imaging1 - mild alzheimer's disease1 - memory losses1 - alpha-synuclein diseases1 - parkinson's disease risk1 - cognitive performance1 - basal ganglia1 - haldol1 - risk of death1 - preparing for appointment1 - atypical alzheimer disease1 - peripheral arterial disease1 - huntington’s disease2 - amyloid markers1 - antipsychotics1 - alzheimers society2 - development of parkinson's1 - voluntary exercise1 - alcohol related dementia1 - tetrahydrocannabinol1 - anticholinergics1 - pet1 -